Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
Revision | Operations | |
---|---|---|
05-23-21 by conan.macdougal... | current revision | |
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
08-12-20 by conan.macdougal... | ||
07-10-20 by [email protected] | ||
04-21-20 by ucsf_admin | ||
04-21-20 by ucsf_admin | ||
04-20-20 by ucsf_admin |
Dosing: Adult Antimicrobial Dosing, Non-dialysis
Indication | Dosing | Notes |
---|---|---|
All Indications | 300 mg PO Q24h | No renal dose adjustment |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
---|---|---|
All Indications | 300mg PO qPM | 300mg PO q24h |
Dialysis Notes
Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.
Any patients with confirmed or suspected active TB disease are required by law to be reported within 1 working day of identification to the TB Control Section. For more detail see: https://www.sfcdcp.org/tb-control/tuberculosis-information-for-medical-providers/reporting-tb-to-the-health-department/#:~:text=Reporting%20TB%20to%20the%20Health%20Department&text=Call%20(628)%20206-3398,554-3613%20for%20urgent%20reporting